26 results
DEFA14A
ACGN
Aceragen Inc
30 Sep 22
Additional proxy soliciting materials
4:18pm
be subject to a contractual standard of materiality that may be different from what may be viewed as material to investors or security holders, or may have
8-K
ACGN
Aceragen Inc
30 Sep 22
Entry into a Material Definitive Agreement
4:15pm
to a contractual standard of materiality that may be different from what may be viewed as material to investors or security holders, or may have been used
8-K
ACGN
Aceragen Inc
2 Jun 20
Regulation FD Disclosure
8:33am
as to the materiality of any information herein (including Exhibits 99.1) that is required to be disclosed solely by Regulation FD.
Item 9.01.
Financial Statements
8-K
ACGN
Aceragen Inc
21 Apr 20
Idera Pharmaceuticals Announces Final Clinical Safety and Efficacy Data from ILLUMINATE-204 Trial in Advanced Melanoma
8:00am
as to the materiality of any information herein (including Exhibit 99.1) that is required to be disclosed solely by Regulation FD.
Item 9.01.
Financial
8-K
mp10 k12u
5 Mar 20
Regulation FD Disclosure
8:00am
8-K
qdbcx5pujpjzw5t4yf
15 Jan 20
38 th Annual JP Morgan Healthcare Conference
7:05am
8-K
889jners4av2l1f
14 Jan 20
Regulation FD Disclosure
7:05am
8-K
27sg9s
31 Oct 19
October 2019 Corporate Update
5:14pm
8-K
31e0j
4 Sep 19
Idera Pharmaceuticals Announces Immuno-Oncology Clinical Research Collaboration with AbbVie
7:05am
8-K
p7zu066d3ttfj
29 Aug 19
Regulation FD Disclosure
4:03pm
8-K
oe5u2xb02wz4 v79cysf
20 Jun 19
Idera Pharmaceuticals 2019 JMP Securities Life Sciences Conference June 2019
8:30am
8-K
a9qffdixctr6nog
7 Jan 19
Idera Pharmaceuticals 37th Annual J.P. Morgan Healthcare Conference January 2019
7:45am
8-K
flcozbq
14 Dec 18
Idera Pharmaceuticals ILLUMINATE-204 Clinical Data Update December 2018
7:06am
8-K
so970mdw4r2ffhcr8
19 Sep 18
Idera Pharmaceuticals Announces Appointment of Howard Pien to its Board of Directors
9:15am
8-K
bzczmuebk5ot
13 Sep 18
Idera Pharmaceuticals Announces Corporate Organizational Changes
12:00am
425
rd6cl 85a81e
22 Jan 18
Business combination disclosure
12:00am